This 2-day event will gather top-level open innovation professionals in order to discuss dramatic shift to “openness” the industry is currently facing. Participants will gain insight on the regulatory environment and discuss the need of regulations, learn how to leverage the Open Innovation Ecosystem for Drug Discovery, how to utilise the thriving new business models, and much more.
Learn more at:
http://pharma.flemingeurope.com/innovation-pharma-rd